-EGPA:

Quanzhen Liu1,2, Zijie Luo1,3, Yanjuan Wu1

  • 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510160, Guangdong, China.

Clinical rheumatology
|June 11, 2025
PubMed
概括

这项研究揭示了肠道细菌和炎症性细胞因子素之间的因果关系,这些因子素是以多炎 (EGPA) 亚型的埃索诺菲尔粒状瘤症. 研究结果表明,这种自身免疫性疾病可能是新的治疗点.